Top compounds associated with response to AL356053.1


Feature Type Standardized
Nominal ANOVA
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.079 0.02
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.02
mRNA Bortezomib FIMM pan-cancer AAC -0.33 0.02
mRNA QS11 GDSC1000 pan-cancer AAC 0.079 0.02
mRNA Irinotecan gCSI pan-cancer AAC -0.12 0.02
mRNA BRD-K26531177 CTRPv2 pan-cancer AAC 0.084 0.02
mRNA Vorinostat gCSI pan-cancer AAC -0.11 0.02
mRNA Z-LLNle-CHO GDSC1000 pan-cancer AAC -0.11 0.02
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.03
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.03
Download CSV